File Download
  Patent History
  • Application
    PC T/CN2014086416 2014-09-12
  • Publication
    WO 2015035941 2015-03-19
  Patent Family

granted patent: USE OF ANNEXIN A3 AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET FOR TREATING HEPATOCELLULAR CARCINOMA

TitleUSE OF ANNEXIN A3 AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET FOR TREATING HEPATOCELLULAR CARCINOMA
Priority Date2013-09-12 US 12/1877061P
Inventors
Issue Date2015
Citation
WO Patent WO 2015035941. World Intellectual Property Organization (WIPO), PatentScope, 2015 How to Cite?
AbstractAnnexin A3 (ANAX3) is utilized as a biomarker for the diagnosis and prognosis of hepatocellular carcinoma (HCC) and the utilization of a monoclonal antibody against ANXA3 or antisense polynucleotide against ANXA3 mRNA for the suppression or treatment of HCC, alone or in combination with other HCC treatment. Monoclonal antibody against ANXA3 can be administered for the suppression of tumor growth, metastasis, and chemoresistance.
Persistent Identifierhttp://hdl.handle.net/10722/210481
References

 

DC FieldValueLanguage
dc.date.accessioned2015-06-17T07:02:22Z-
dc.date.available2015-06-17T07:02:22Z-
dc.date.issued2015-
dc.identifier.citationWO Patent WO 2015035941. World Intellectual Property Organization (WIPO), PatentScope, 2015-
dc.identifier.urihttp://hdl.handle.net/10722/210481-
dc.description.abstractAnnexin A3 (ANAX3) is utilized as a biomarker for the diagnosis and prognosis of hepatocellular carcinoma (HCC) and the utilization of a monoclonal antibody against ANXA3 or antisense polynucleotide against ANXA3 mRNA for the suppression or treatment of HCC, alone or in combination with other HCC treatment. Monoclonal antibody against ANXA3 can be administered for the suppression of tumor growth, metastasis, and chemoresistance.-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License for public patent documents-
dc.titleUSE OF ANNEXIN A3 AS A DIAGNOSTIC AND PROGNOSTIC BIOMARKER AND THERAPEUTIC TARGET FOR TREATING HEPATOCELLULAR CARCINOMA-
dc.typePatent-
dc.identifier.authorityMA, KWAI YEE STEPHANIE=rp00506-
dc.identifier.authorityGUAN, XINYUAN=rp00454-
dc.description.naturepublished_or_final_version-
dc.contributor.inventorGUAN, XINYUAN-
dc.contributor.inventorMA, KWAI YEE STEPHANIE-
dc.contributor.inventorTONG, MAN-
patents.identifier.applicationPC T/CN2014086416-
patents.description.assigneeUNIV HONG KONG [CN] -
patents.description.countryWorld Intellectual Property Organization (WIPO) -
patents.date.publication2015-03-19-
dc.relation.references W O2007141043 (A3) 2008-03-20-
dc.relation.referencesWO 2007141043 (A2) 2007-12-13 -
patents.identifier.hkutechidOnco-2013-00467-2-
patents.date.application2014-09-12-
patents.date.priority2013-09-12 US 12/1877061P-
patents.description.ccwo-
patents.identifier.publicationWO 2015035941-
patents.relation.familyUS 2015071933 (A1) 2015-03-12-
patents.description.kindA1-
patents.typePatent_granted-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats